These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 7570266)

  • 1. [Is there any clinical significance to anti-IgA antibodies which appear in patients with immunodeficiencies treated with intravenous gamma globulin?].
    Ferreira A; Cruz García Rodríguez M; Martín J; Fontán G
    Sangre (Barc); 1995 Jun; 40(3):171-3. PubMed ID: 7570266
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful gamma globulin therapy in a patient with anti-IgA antibodies].
    Litzman J; Broz P; Král V; Lokaj J
    Vnitr Lek; 1997 Feb; 43(2):102-4. PubMed ID: 9245064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indications for intravenous immunoglobulins].
    Spertini F
    Rev Med Suisse Romande; 1993 Mar; 113(3):179-82. PubMed ID: 8480110
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin.
    Ferreira A; Garcia Rodriguez MC; Lopez-Trascasa M; Pascual Salcedo D; Fontan G
    Clin Immunol Immunopathol; 1988 May; 47(2):199-207. PubMed ID: 2450712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature.
    Rachid R; Bonilla FA
    J Allergy Clin Immunol; 2012 Mar; 129(3):628-34. PubMed ID: 21835445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy.
    Horn J; Thon V; Bartonkova D; Salzer U; Warnatz K; Schlesier M; Peter HH; Grimbacher B
    Clin Immunol; 2007 Feb; 122(2):156-62. PubMed ID: 17137841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of anti-IgA antibodies with adverse reactions to γ-globulin infusion.
    Rachid R; Castells M; Cunningham-Rundles C; Bonilla FA
    J Allergy Clin Immunol; 2011 Jul; 128(1):228-230.e1. PubMed ID: 21397310
    [No Abstract]   [Full Text] [Related]  

  • 8. Follow-up of anti-IgA antibodies in primary immunodeficient patients treated with gamma-globulin.
    Ferreira A; García Rodriguez MC; Fontán G
    Vox Sang; 1989; 56(4):218-22. PubMed ID: 2474899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary immunodeficiency or not? Making the correct diagnosis.
    Buckley RH
    J Allergy Clin Immunol; 2006 Apr; 117(4):756-8. PubMed ID: 16630930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-IgA antibody associated reactions to intravenous gammaglobulin in a patient who tolerated intramuscular gammaglobulin.
    Frankel SJ; Polmar SH; Grumet FC; Wedner HJ
    Ann Allergy; 1986 May; 56(5):436-9. PubMed ID: 2422990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective IgA deficiency.
    Burks AW; Steele RW
    Ann Allergy; 1986 Jul; 57(1):3-13. PubMed ID: 3487995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgG anti-IgA antibodies in paediatric antibody-deficient patients receiving intravenous immunoglobulin.
    Torabi Sagvand B; Mirminachi B; Abolhassani H; Shokouhfar T; Keihanian T; Amirzargar A; Mahdaviani A; Aghamohammadi A
    Allergol Immunopathol (Madr); 2015; 43(4):403-8. PubMed ID: 25201762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversible Hypogammaglobulinemia in 2 Pediatric Patients With Primary Immunodeficiency.
    Pasic S
    J Investig Allergol Clin Immunol; 2017; 27(5):320-321. PubMed ID: 29057740
    [No Abstract]   [Full Text] [Related]  

  • 14. Primary immunodeficiencies.
    Cooper MA; Pommering TL; Korányi K
    Am Fam Physician; 2003 Nov; 68(10):2001-8. PubMed ID: 14655810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new intravenous immunoglobulin (BIVIGAM®) for primary humoral immunodeficiency.
    Wasserman RL
    Expert Rev Clin Immunol; 2014 Mar; 10(3):325-37. PubMed ID: 24527947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for the use of human immunoglobulin therapy in patients with primary immunodeficiencies in Latin America.
    Condino-Neto A; Costa-Carvalho BT; Grumach AS; King A; Bezrodnik L; Oleastro M; Leiva L; Porras O; Espinosa-Rosales FJ; Franco JL; Sorensen RU
    Allergol Immunopathol (Madr); 2014; 42(3):245-60. PubMed ID: 23333411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of intravenous immunoglobulin preparations (IVIG) in treatment of primary cell immunodeficiencies].
    Siwińska-Gołebiowska H; Czerwińska-Kartowicz I; Markiewicz K
    Postepy Hig Med Dosw; 2002; 56 Suppl():33-40. PubMed ID: 12661412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic syndromic immunodeficiencies with antibody defects.
    Ming JE; Stiehm ER
    Immunol Allergy Clin North Am; 2008 Nov; 28(4):715-36, vii. PubMed ID: 18940571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-immunoglobulin antibodies in immunodeficiencies: their influence on intolerance reactions to gamma-globulin administration.
    Ropars C; Caldera LH; Griscelli C; Homberg JC; Salmon C
    Vox Sang; 1974; 27(4):294-301. PubMed ID: 4137541
    [No Abstract]   [Full Text] [Related]  

  • 20. Anaphylaxis to IVIG.
    Williams SJ; Gupta S
    Arch Immunol Ther Exp (Warsz); 2017 Feb; 65(1):11-19. PubMed ID: 27412077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.